Research Article
Suppression of lncRNA MALAT1 Reduces LPS- or IL-17A-Induced Inflammatory Response in Human Middle Ear Epithelial Cells via the NF-κB Signaling Pathway
Figure 5
MALAT1 promotes LPS- or IL-17A-induced inflammatory response through the NF-κB pathway. (a) The overexpression efficacy of pcDNA3.1/MALAT1 in HMEECs was detected by RT-qPCR analysis. (b–g) The effects of MALAT1 and QNZ on concentrations of inflammatory cytokines (TNF-α, IL-β, and IL-6) were evaluated by ELISA assay in HMEECs under LPS or IL-17A treatment. (h, i) The effects of MALAT1 and QNZ on protein levels of MUC5AC and MUC8 were measured by western blot in LPS- or IL-17A-induced HMEECs. , .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |